Search Result

Results for "

B7-H3 (CD276)

" in MedChemExpress (MCE) Product Catalog:

By Targets:	CD276/B7-H3 (4) CD47 (1) ADC Antibody (1) Antibody-Drug Conjugates (ADCs) (2) Apoptosis (2) STAT (1) Topoisomerase (1)
By Research Areas:	Cancer (6) Inflammation/Immunology (2)

Inhibitors & Agonists

Fluorescent Dyes

Inhibitory Antibodies

Recombinant Proteins

Antibodies

Targets Recommended: CD276/B7-H3 CD1 CD38 CD28 CD19 CD20 CD22 Transferrin Receptor CD3 P-selectin CD6 CD2 CD73 c-Kit LAG-3 L-Selectin CTLA-4 CD47 ALCAM/CD166 Neprilysin E-Selectin Scavenger Receptor Class B type I (SR-BI） FLT3 Tim3 CD44 Anaplastic lymphoma kinase (ALK) CD74 Human leukocyte immunoglobulin (Ig)-like receptors (LILR) P-glycoprotein

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P3371

Ifinatamab deruxtecan DS-7300a; MABX-9001a; I-DXd	Antibody-Drug Conjugates (ADCs) Topoisomerase Apoptosis	Cancer
Ifinatamab deruxtecan (DS-7300a) is a B7-H3-targeting Antibody-drug conjugate (ADC), which is composed of a humanized anti-B7-H3 monoclonal antibody, an enzymatically cleavable peptide-based linker, and Exatecan derivative (DXd) (HY-13631D). Ifinatamab deruxtecan is a DNA Topoisomerase I inhibitor. Ifinatamab deruxtecan induces Apoptosis. DS-7300a exerts potent antitumor activities against B7-H3-expressing tumors. against rhabdomyosarcoma, endometrial adenocarcinoma and lung adenocarcinoma. Ifinatamab deruxtecan does not exert direct immunomodulatory effects

HY-P99157

Omburtamab	CD276/B7-H3	Cancer
Omburtamab is a humanized monoclonal antibody targeting **B7-H3 (CD276). Omburtamab selectively binds to B7-H3 highly expressed on the surface of tumor cells and activates anti-tumor immune responses mediated by T cells and natural killer (NK) cells. Omburtamab can promote the specific infiltration of CAR-T cells into tumors, enhance the killing function of NK cells through the CD16 signaling pathway, and regulate tumor cell glucose metabolism (such as inhibiting the Warburg** effect). Omburtamab has the potential to inhibit solid tumors such as non-small cell lung cancer (NSCLC) .

HY-P99740

Mirzotamab	CD276/B7-H3 ADC Antibody	Cancer
Mirzotamab is an IgG1κ monoclonal antibody targeting to *CD276/B7-H3* with anti-tumor activity. Mirzotamab conjugates with Clezutoclax (HY-137774), a BCL inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate (ADC) .

HY-P990279

*Anti-Mouse CD276/B7-H3* Antibody (MJ18)**	CD276/B7-H3 Apoptosis STAT	Inflammation/Immunology Cancer
Anti-Mouse CD276/B7-H3 Antibody (MJ18) is a rat-derived anti-mouse *CD276/B7-H3* IgG1 monoclonal antibody. Anti-Mouse CD276/B7-H3 Antibody (MJ18) can inhibit CD276/B7-H3 and induce tumor cell apoptosis. Anti-Mouse CD276/B7-H3 Antibody (MJ18) enhances anti-tumor immune response by reducing immunosuppressive cells and promoting T cell activation. Anti-Mouse CD276/B7-H3 Antibody (MJ18) can be used for research on cancer such as breast cancer and prostate cancer .

HY-145636

Vobramitamab duocarmazine AEX4089DC1; MGC018	Antibody-Drug Conjugates (ADCs)	Cancer
Vobramitamab duocarmazine (AEX4089DC1; MGC018), a humanized antibody-drug conjugate (ADC) targeted against **B7-H3 (CD276)*. Vobramitamab duocarmazine is comprised of the cleavable linker-Duocarmycin payload, Vc-seco-DUBA (HY-128957), conjugated to an anti-B7-H3* humanized IgG1κ monoclonal antibody. Vobramitamab duocarmazine has antineoplastic activity .

HY-P990340

*Anti-B7-H3/CD276* Antibody**	CD276/B7-H3	Inflammation/Immunology
Anti-B7-H3/CD276 Antibody is a CHO-expressed human antibody targeting *B7-H3/CD276. Anti-B7-H3/CD276* Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Anti-B7-H3/CD276 Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P992158

VBI-009	CD47	Cancer
VBI-009 is a CD47 and *B7-H3* (CD276) bispecific antibody. VBI-009 blocks CD47-SIRPα 'don't eat me' signals and restricts activity to CD47 ⁺/B7-H3 ⁺ cells. VBI-009 induces antibody-dependent cellular phagocytosis (ADCP) and antibody-dependent cellular cytotoxicity (ADCC) in CD47 ⁺/B7-H3 ⁺ tumor cells. VBI-009 inhibits tumor growth in CD47+/B7-H3+ lung cancer xenograft models. VBI-009 can be used for the research of lung cancer .

Cat. No.	Product Name	Type

HY-P3371

Ifinatamab deruxtecan DS-7300a; MABX-9001a; I-DXd	Fluorescent Dyes
Ifinatamab deruxtecan (DS-7300a) is a B7-H3-targeting Antibody-drug conjugate (ADC), which is composed of a humanized anti-B7-H3 monoclonal antibody, an enzymatically cleavable peptide-based linker, and Exatecan derivative (DXd) (HY-13631D). Ifinatamab deruxtecan is a DNA Topoisomerase I inhibitor. Ifinatamab deruxtecan induces Apoptosis. DS-7300a exerts potent antitumor activities against B7-H3-expressing tumors. against rhabdomyosarcoma, endometrial adenocarcinoma and lung adenocarcinoma. Ifinatamab deruxtecan does not exert direct immunomodulatory effects

Ifinatamab deruxtecan

DS-7300a; MABX-9001a; I-DXd

Fluorescent Dyes

Ifinatamab deruxtecan (DS-7300a) is a B7-H3-targeting Antibody-drug conjugate (ADC), which is composed of a humanized anti-B7-H3 monoclonal antibody, an enzymatically cleavable peptide-based linker, and Exatecan derivative (DXd) (HY-13631D). Ifinatamab deruxtecan is a DNA Topoisomerase I inhibitor. Ifinatamab deruxtecan induces Apoptosis. DS-7300a exerts potent antitumor activities against B7-H3-expressing tumors. against rhabdomyosarcoma, endometrial adenocarcinoma and lung adenocarcinoma. Ifinatamab deruxtecan does not exert direct immunomodulatory effects

Cat. No.	Product Name	Target	Research Area	Image

HY-P3371

Ifinatamab deruxtecan DS-7300a; MABX-9001a; I-DXd	Antibody-Drug Conjugates (ADCs) Topoisomerase Apoptosis	Cancer
Ifinatamab deruxtecan (DS-7300a) is a B7-H3-targeting Antibody-drug conjugate (ADC), which is composed of a humanized anti-B7-H3 monoclonal antibody, an enzymatically cleavable peptide-based linker, and Exatecan derivative (DXd) (HY-13631D). Ifinatamab deruxtecan is a DNA Topoisomerase I inhibitor. Ifinatamab deruxtecan induces Apoptosis. DS-7300a exerts potent antitumor activities against B7-H3-expressing tumors. against rhabdomyosarcoma, endometrial adenocarcinoma and lung adenocarcinoma. Ifinatamab deruxtecan does not exert direct immunomodulatory effects

HY-P99157

Omburtamab	CD276/B7-H3	Cancer
Omburtamab is a humanized monoclonal antibody targeting **B7-H3 (CD276). Omburtamab selectively binds to B7-H3 highly expressed on the surface of tumor cells and activates anti-tumor immune responses mediated by T cells and natural killer (NK) cells. Omburtamab can promote the specific infiltration of CAR-T cells into tumors, enhance the killing function of NK cells through the CD16 signaling pathway, and regulate tumor cell glucose metabolism (such as inhibiting the Warburg** effect). Omburtamab has the potential to inhibit solid tumors such as non-small cell lung cancer (NSCLC) .

HY-P99740

Mirzotamab	CD276/B7-H3 ADC Antibody	Cancer
Mirzotamab is an IgG1κ monoclonal antibody targeting to *CD276/B7-H3* with anti-tumor activity. Mirzotamab conjugates with Clezutoclax (HY-137774), a BCL inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate (ADC) .

HY-P990279

*Anti-Mouse CD276/B7-H3* Antibody (MJ18)**	CD276/B7-H3 Apoptosis STAT	Inflammation/Immunology Cancer
Anti-Mouse CD276/B7-H3 Antibody (MJ18) is a rat-derived anti-mouse *CD276/B7-H3* IgG1 monoclonal antibody. Anti-Mouse CD276/B7-H3 Antibody (MJ18) can inhibit CD276/B7-H3 and induce tumor cell apoptosis. Anti-Mouse CD276/B7-H3 Antibody (MJ18) enhances anti-tumor immune response by reducing immunosuppressive cells and promoting T cell activation. Anti-Mouse CD276/B7-H3 Antibody (MJ18) can be used for research on cancer such as breast cancer and prostate cancer .

HY-P990340

*Anti-B7-H3/CD276* Antibody**	CD276/B7-H3	Inflammation/Immunology
Anti-B7-H3/CD276 Antibody is a CHO-expressed human antibody targeting *B7-H3/CD276. Anti-B7-H3/CD276* Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Anti-B7-H3/CD276 Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P992158

VBI-009	CD47	Cancer
VBI-009 is a CD47 and *B7-H3* (CD276) bispecific antibody. VBI-009 blocks CD47-SIRPα 'don't eat me' signals and restricts activity to CD47 ⁺/B7-H3 ⁺ cells. VBI-009 induces antibody-dependent cellular phagocytosis (ADCP) and antibody-dependent cellular cytotoxicity (ADCC) in CD47 ⁺/B7-H3 ⁺ tumor cells. VBI-009 inhibits tumor growth in CD47+/B7-H3+ lung cancer xenograft models. VBI-009 can be used for the research of lung cancer .

Recombinant Proteins Recommended:

B7-H3/CD276

Species:	Human (11) Rat (2) Mouse (2) Cynomolgus (2)
Tag:	His (10) Avi (4) Myc (1) Fc (7)
Source:	HEK293 (17)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P70125

	CD276/B7-H3 Protein, Cynomolgus (HEK293, His) rCynCD276/B7-H3, His; CD276 antigen; CD276; B7 homolog 3; B7-H3; CD276; Cynomolgus CD276	Cynomolgus	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived CD276/B7-H3 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P70126

	CD276/B7-H3 Protein, Cynomolgus (HEK293, Fc) rCynCD276/B7-H3, Fc; CD276 antigen; CD276; B7 homolog 3; B7-H3; CD276; Cynomolgus CD276 Molecule	Cynomolgus	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Cynomolgus (HEK293, Fc) is the recombinant cynomolgus-derived CD276/B7-H3 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P700880

	CD276/B7-H3 Protein, Human (Biotinylated, HEK293, C-His-Avi) B7H3; B7-H3; CD276; PSEC0249; UNQ309; PRO352; B7 homolog 3; CD276	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Human (Biotinylated, HEK293, C-His-Avi) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-Avi, C-His labeled tag.

HY-P7639

	CD276/B7-H3 Protein, Mouse (HEK293, His) 1 Publications Verification rMuB7-H3, His; CD276 antigen; CD276; B7 homolog 3; B7-H3; CD276	Mouse	HEK293
	CD276/B7-H3 Protein, Mouse (HEK293, His) is induced upon T cell activation. B7-H3 selectively increases the production of IFN-γ.

HY-P705245

	CD276/B7-H3 Protein, Mouse (Biotinylated, HEK293, His-Avi) rMuB7-H3, His; CD276 antigen; CD276; B7 homolog 3; B7-H3; CD276	Mouse	HEK293

HY-P70652

	CD276/B7-H3 (4Ig)/B7-H3b Protein, Human (HEK293, His) CD276; B7H34Ig-B7-H3; B7-H3; B7 homolog 3; CD276 antigen; CD276 molecule; Costimulatory molecule	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 (4Ig)/B7-H3b Protein, Human (HEK293, His) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-His labeled tag.

HY-P704456

	*FITC-Labeled CD276/B7-H3* (4Ig)/B7-H3b Protein, Human (HEK293, His)** CD276; CD276 molecule; CD276 antigen; B7 H3; B7H3; B7RP 2; B7 homolog 3; costimulatory molecule; B7-H3; B7RP-2; 4Ig-B7-H3;	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. FITC-Labeled CD276/B7-H3 (4Ig)/B7-H3b Protein, Human (HEK293, His) is the recombinant human-derived FITC-Labeled CD276/B7-H3 protein, expressed by HEK293, with C-His labeled tag.

HY-P78930

	CD276/B7-H3 Protein, Human (Biotinylated, HEK293, Fc-Avi) B7-H3; CD276; B7 homolog 3	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 Protein, Human (Biotinylated, HEK293, Fc-Avi) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-Avi, C-hFc labeled tag.

HY-P700448

	CD276/B7-H3 (4Ig)/B7-H3b Protein, Human (217a.a, HEK293, Myc-hFc) CD276; CD276 molecule; CD276 antigen; B7 H3; B7H3; B7RP 2; B7 homolog 3; costimulatory molecule; B7-H3; B7RP-2; 4Ig-B7-H3;	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 (4Ig)/B7-H3b Protein, Human (217a.a, HEK293, Myc-hFc) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-Myc, C-hFc labeled tag.

HY-P78074

	CD276/B7-H3 (4Ig)/B7-H3b Protein, Human (Biotinylated, HEK293, His-Avi) B7-H3; CD276; PSEC0249; 4Ig-B7-H3; UNQ309; PRO352; B7 homolog 3; CD276	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 (4Ig)/B7-H3b Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-Avi, C-His labeled tag.

HY-P74314

	CD276/B7-H3 Protein, Rat (HEK293, His) B7H3; B7-H3B7 homolog 3; CD276; Costimulatory molecule	Rat	HEK293
	CD276/B7-H3 Protein regulates T-cell-mediated immune responses and transplant rejection. It also promotes bone formation, functioning at the bone-immune interface. Additionally, it activates immune responses against tumors, eliminating them through natural killer cells and CD8 T-cells. Its interaction with TREML2 enhances T-cell activation, highlighting its role in immune regulation. CD276/B7-H3 Protein, Rat (HEK293, His) is the recombinant rat-derived CD276/B7-H3 protein, expressed by HEK293 , with C-His labeled tag.

HY-P74315

	CD276/B7-H3 Protein, Rat (HEK293, Fc) B7H3; B7-H3B7 homolog 3; CD276; Costimulatory molecule	Rat	HEK293
	CD276/B7-H3 Protein regulates T-cell-mediated immune responses and transplant rejection. It also promotes bone formation, functioning at the bone-immune interface. Additionally, it activates immune responses against tumors, eliminating them through natural killer cells and CD8 T-cells. Its interaction with TREML2 enhances T-cell activation, highlighting its role in immune regulation. CD276/B7-H3 Protein, Rat (HEK293, Fc) is the recombinant rat-derived CD276/B7-H3 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P74317

	CD276/B7-H3 (4Ig)/B7-H3b Protein, Human (HEK293, hFc) B7H3; B7-H3B7 homolog 3; CD276; Costimulatory molecule	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 (4Ig)/B7-H3b Protein, Human (HEK293, hFc) is the recombinant human-derived CD276/B7-H3, expressed by HEK293, with C-hFc labeled tag.

HY-P7327

	CD276/B7-H3 Protein, Human (HEK293, His) rHuB7-H3/ICOSLG, His; B7H3; B7 homolog 3; CD276	Human	HEK293
	CD276/B7-H3 Protein, Human (HEK293, His) is a polypeptide chain containing the C-termimal His tag produced in HEK293 cells. B7-H3 is an immune checkpoint from the B7 family of molecules.

HY-P77538

	CD276/B7-H3 (4Ig)/B7-H3b Protein, Human (Biotinylated, HEK293, His) B7H3; B7-H3B7 homolog 3; CD276; Costimulatory molecule	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. CD276/B7-H3 (4Ig)/B7-H3b Protein, Human (Biotinylated, HEK293, His) is the recombinant human-derived CD276/B7-H3 protein, expressed by HEK293 , with C-His labeled tag.

HY-P7326

	CD276/B7-H3 Protein, Human (HEK293, Fc) rHuB7-H3/ICOSLG, Fc Chimera; B7H3; B7 homolog 3; CD276	Human	HEK293
	CD276/B7-H3 Protein, Human (HEK293, Fc) is a polypeptide chain containing the C-termimal His tag produced in HEK293 cells. B7-H3 is an immune checkpoint from the B7 family of molecules.

HY-P701302

	*FITC-Labeled CD276/B7-H3* (4Ig)/B7-H3b Protein, Human (HEK293, Fc)** 4Ig-B7-H3; B7-H3; CD276; PSEC0249; UNQ309; PRO352; B7 homolog 3	Human	HEK293
	CD276/B7-H3 protein can regulate T cell-mediated immune responses and act as a protective factor for tumor cells by inhibiting natural killer-mediated cell lysis. It also functions as a neuroblastoma cell marker, plays a role in acute and chronic transplant rejection, and modulates lymphocyte activity at mucosal surfaces. FITC-Labeled CD276/B7-H3 (4Ig)/B7-H3b Protein, Human (HEK293, Fc) is the recombinant human-derived FITC-Labeled CD276/B7-H3 protein, expressed by HEK293 , with Fc labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Host:	Mouse (5) Rabbit (2)
Reactivity:	Human (7) Rat (3) Mouse (3) Monkey (2) Rabbit (2)
Application:	IHC-P (5) ICC/IF (4) WB (4) FC (3) ELISA (5)
Isotype:	IgG (2) IgG1 (2)
Conjugation:	Non-conjugated (7) Biotin (5)
Clonality:	Monoclonal (5) Recombinant (1)
Modification:	Unmodified (5)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P81534

	CD276 Antibody (YA1279) CD276; B7H3; PSEC0249; CD276 antigen; 4Ig-B7-H3; B7 homolog 3; B7-H3; Costimulatory molecule; CD276	IHC-P	Human
	CD276 Antibody (YA1279) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CD276.

HY-P84983

	CD276/B7H3 Antibody (YA4675) CD276; B7H3; PSEC0249; CD276 antigen; 4Ig-B7-H3; B7 homolog 3; B7-H3; Costimulatory molecule; CD antigen CD276; CD276 nanobody; B7H3 nanobody;	ELISA	Human
	CD276/B7H3 Antibody (YA4675) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CD276/B7H3.

HY-P84637

	CD276/B7H3 Antibody (YA4334) B7H3; B7-H3; 4Ig-B7-H3; CD276	WB, IHC-P, ICC/IF, FC, ELISA	Human, Mouse, Rat, Rabbit, Monkey
	CD276/B7H3 Antibody (YA4334) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CD276/B7H3.

HY-P81534A

	CD276 Antibody (YA1279)(PBS only) CD276; B7H3; PSEC0249; CD276 antigen; 4Ig-B7-H3; B7 homolog 3; B7-H3; Costimulatory molecule; CD276	IHC-P	Human
	CD276 Antibody (YA1279) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CD276.

HY-P85833

	CD276/B7H3 Antibody (YA5525) CD276; B7H3; PSEC0249; CD276 antigen; 4Ig-B7-H3; B7 homolog 3; B7-H3; Costimulatory molecule; CD276	WB, ICC/IF, ELISA	Human, Mouse, Rat
	CD276/B7H3 Antibody (YA5525) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CD276/B7H3.

HY-P84637A

	CD276/B7H3 Antibody (YA4334)(PBS only) B7H3; B7-H3; 4Ig-B7-H3; CD276	WB, IHC-P, ICC/IF, FC, ELISA	Human, Mouse, Rat, Rabbit, Monkey
	CD276/B7H3 Antibody (YA4334) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CD276/B7H3.

HY-P85087

	CD276/B7H3 Antibody (YA4779) CD276; B7H3; PSEC0249; CD276 antigen; 4Ig-B7-H3; B7 homolog 3; B7-H3; Costimulatory molecule; CD antigen CD276	WB, IHC-P, ICC/IF, FC, ELISA	Human
	CD276/B7H3 Antibody (YA4779) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CD276/B7H3.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: